Zhiqiang Feng

发表

Novel multi-kinase inhibitor, T03 inhibits Taxol-resistant breast cancer

Y. Li, Jindong Chen, Chunxia Liu, 2017, Molecular medicine reports.

The potential role of glucokinase activator SHP289‐04 in anti‐diabetes and hepatic protection

Shuainan Liu, Quan Liu, Z. Shen, 2018, European journal of pharmacology.

Antidiabetic potential of a novel dual-target activator of glucokinase and peroxisome proliferator activated receptor-γ.

Shuainan Liu, Quan Liu, Z. Shen, 2015, Metabolism: clinical and experimental.

Silencing Aurora A leads to re-sensitization of breast cancer cells to Taxol through downregulation of SRC-mediated ERK and mTOR pathways

Y. Li, Jindong Chen, Xiaoguang Chen, 2017, Oncology reports.

Novel N-(pyrimidin-4-yl)thiazol-2-amine derivatives as dual-action hypoglycemic agents that activate GK and PPARγ

Z. Shen, Hui-peng Song, K. Tian, 2011 .

Novel phenyl-urea derivatives as dual-target ligands that can activate both GK and PPARγ

Z. Shen, K. Tian, Zhiqiang Feng, 2012 .

Activity of the potent dual Abl/Src tyrosine kinase inhibitor FB2 against Bcr-Abl positive cell lines in vitro and in vivo.

Xiangyan Li, Xiaoguang Chen, Zhiqiang Feng, 2011, Leukemia research.

Activity of FB2, a novel dual Abl/Src tyrosine kinase inhibitor, against imatinib-resistant chronic myeloid leukemia in vivo and in vitro

Hongbo Wang, Sen Zhang, Xiaoguang Chen, 2009, Leukemia & lymphoma.

Design, Synthesis and Biological Evaluation of Phenyl Urea Derivatives as IDO1 Inhibitors

Chuan Zhou, Xiaoguang Chen, Yan Li, 2020, Molecules.

Anticancer effects of FL34 through the inhibition of GLI1 in glioblastoma

Chen Yan, Y. Li, Tie-gang Li, 2019, Journal of cancer research and therapeutics.

Synthesis and activity in enhancing long-term potentiation (LTP) of clausenamide stereoisomers.

Zhiqiang Feng, Guo-Xun Zheng, Liang Huang, 2009, Bioorganic & medicinal chemistry letters.

Acryloylamino-salicylanilides as EGFR PTK inhibitors.

Yan-shen Guo, Zongru Guo, F. Chu, 2006, Bioorganic & medicinal chemistry letters.

Simultaneous Determination of a Novel PD-L1 Inhibitor, IMMH-010, and Its Active Metabolite, YPD-29B, in Rat Biological Matrices by Polarity-Switching Liquid Chromatography-Tandem Mass Spectrometry: Application to ADME Studies

Xiaoguang Chen, Yuke Liu, Yan Li, 2021, Frontiers in Pharmacology.

The molecular mechanisms of a novel multi-kinase inhibitor ZLJ33 in suppressing pancreatic cancer growth.

C. Li, Y. Li, Xiaoguang Chen, 2015, Cancer letters.

Design, synthesis, and structure-activity relationship of PD-1/PD-L1 inhibitors with a benzo[d]isoxazole scaffold.

Zhiqiang Feng, Ke Wang, Hao Chen, 2021, Bioorganic & medicinal chemistry letters.

Design, synthesis, and structure-activity relationship of programmed cell death-1/programmed cell death-ligand 1 interaction inhibitors bearing a benzo[d]isothiazole scaffold.

Zhiqiang Feng, Ke Wang, Hao Chen, 2021, European journal of medicinal chemistry.

Design, synthesis, evaluation, and SAR of 4-phenylindoline derivatives, a novel class of small-molecule inhibitors of the programmed cell death-1/ programmed cell death-ligand 1 (PD-1/PD-L1) interaction.

Zhiqiang Feng, Ke Wang, Hao Chen, 2020, European journal of medicinal chemistry.

Discovery of novel urea derivatives as dual-target hypoglycemic agents that activate glucokinase and PPARγ.

Z. Shen, K. Tian, Zhiqiang Feng, 2014, European journal of medicinal chemistry.

YPD-30, a prodrug of YPD-29B, is an oral small-molecule inhibitor targeting PD-L1 for the treatment of human cancer

T. Du, Yunchen Wang, Xiaoguang Chen, 2022, Acta pharmaceutica Sinica. B.

Synthesis and anti-proliferative activity evaluation of sorafenib derivatives with a 3-arylacryloyl hydrazide unit

Y. Li, Zhiqiang Feng, Xiao-guang Chen, 2015, Medicinal Chemistry Research.

A targeted covalent inhibitor of p97 with proteome-wide selectivity

S. Yao, Chong-Jing Zhang, Zhiqiang Feng, 2021, Acta pharmaceutica Sinica. B.

Design, synthesis and biological evaluation of novel glucokinase activators

Yong Qiang Li, Yu Ling Wang, Zhiqiang Feng, 2011 .

Design, synthesis, and biological evaluation of 1-methyl-1H-pyrazolo[4,3-b]pyridine derivatives as novel small-molecule inhibitors targeting the PD-1/PD-L1 interaction.

Zhiqiang Feng, Ke Wang, Hao Chen, 2021, Bioorganic chemistry.

Design, Synthesis, and Activity Evaluation of GK/PPARγ Dual‐Target‐Directed Ligands as Hypoglycemic Agents

Z. Shen, Yi Huan, Zhiqiang Feng, 2014, ChemMedChem.

Synthesis and structure-activity relationships of N - (3 - (1H-imidazol-2-yl) phenyl) - 3-phenylpropionamide derivatives as a novel class of covalent inhibitors of p97/VCP ATPase.

Chong-Jing Zhang, Zhiqiang Feng, Ke Wang, 2023, European journal of medicinal chemistry.

Synthesis and anti-inflammatory activity of the major metabolites of imrecoxib.

Zongru Guo, F. Chu, Zhiqiang Feng, 2009, Bioorganic & medicinal chemistry letters.

The molecular mechanisms of a novel multi-kinase inhibitor ZLJ33 in suppressing pancreatic cancer growth.

C. Li, Y. Li, Xiaoguang Chen, 2015, Cancer letters.